z-logo
Premium
Systemic redox imbalance in severe COVID‐19 patients
Author(s) -
Postiga Isabelle A. L.,
Teixeira Paula C.,
Neves Carla Andretta Moreira,
Santana Filho Paulo,
Marmett Bruna,
Carvalho Roseana,
Peres Alessandra,
Rotta Liane,
Thompson Claudia Elizabeth,
Dorneles Gilson P.,
Romão Pedro R. T.
Publication year - 2022
Publication title -
cell biochemistry and function
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.933
H-Index - 61
eISSN - 1099-0844
pISSN - 0263-6484
DOI - 10.1002/cbf.3735
Subject(s) - oxidative stress , medicine , intensive care unit , reactive oxygen species , lipid peroxidation , apoptosis , covid-19 , immunology , gastroenterology , disease , biology , biochemistry , infectious disease (medical specialty)
The aim of this study was to evaluate the systemic redox state and inflammatory markers in intensive care unit (ICU) or non‐ICU severe COVID‐19 patients during the hospitalization period. Blood samples were collected at hospital admission (T1) (Controls and COVID‐19 patients), 5–7 days after admission (T2: 5–7 days after hospital admission), and at the discharge time from the hospital (T3: 0–72 h before leaving hospital or death) to analyze systemic oxidative stress markers and inflammatory variables. The reactive oxygen species (ROS) production and mitochondrial membrane potential (MMP) were analyzed in peripheral granulocytes and monocytes. THP‐1 human monocytic cell line was incubated with plasma from non‐ICU and ICU COVID‐19 patients and cell viability and apoptosis rate were analyzed. Higher total antioxidant capacity, protein oxidation, lipid peroxidation, and IL‐6 at hospital admission were identified in both non‐ICU and ICU COVID‐19 patients. ICU COVID‐19 patients presented increased C‐reactive protein, ROS levels, and protein oxidation over hospitalization period compared to non‐ICU patients, despite increased antioxidant status. Granulocytes and monocytes of non‐ICU and ICU COVID‐19 patients presented lower MMP and higher ROS production compared to the healthy controls, with the highest values found in ICU COVID‐19 group. Finally, the incubation of THP‐1 cells with plasma acquired from ICU COVID‐19 patients at T3 hospitalization period decreased cell viability and apoptosis rate. In conclusion, disturbance in redox state is a hallmark of severe COVID‐19 and is associated with cell damage and death.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here